AAAAAA

   
Results: 1-13 |
Results: 13
Intrahepatic mRNA levels of interferon gamma and tumor necrosis factor alpha and response to antiviral treatment of chronic hepatitis C
Authors: Dumoulin, FL Wennrich, U Nischalke, HD Leifeld, L Fischer, HP Sauerbruch, T Spengler, U
Citation: Fl. Dumoulin et al., Intrahepatic mRNA levels of interferon gamma and tumor necrosis factor alpha and response to antiviral treatment of chronic hepatitis C, J HUMAN VIR, 4(4), 2001, pp. 195-199
Intrahepatic MxA expression is correlated with interferon-alpha expressionin chronic and fulminant hepatitis
Authors: Leifeld, L Ramakers, J Schneiders, AM Dumoulin, FL Sterneck, M Muller, A Sauerbruch, T Spengler, U
Citation: L. Leifeld et al., Intrahepatic MxA expression is correlated with interferon-alpha expressionin chronic and fulminant hepatitis, J PATHOLOGY, 194(4), 2001, pp. 478-483
Clinical and diagnostic features of hepatits
Authors: Leifeld, L Spengler, U Sauerbruch, T
Citation: L. Leifeld et al., Clinical and diagnostic features of hepatits, DEUT MED WO, 125(48), 2000, pp. 1471-1474
T(H)1 to T(H)2 shift of cytokines in peripheral blood of HIV-infected patients is detectable by reverse transcriptase polymerase chain reaction but not by enzyme-linked immunosorbent assay under nonstimulated conditions
Authors: Altfeld, M Addo, MM Kreuzer, KA Rockstroh, JK Dumoulin, FL Schliefer, K Leifeld, L Sauerbruch, T Spengler, U
Citation: M. Altfeld et al., T(H)1 to T(H)2 shift of cytokines in peripheral blood of HIV-infected patients is detectable by reverse transcriptase polymerase chain reaction but not by enzyme-linked immunosorbent assay under nonstimulated conditions, J ACQ IMM D, 23(4), 2000, pp. 287-294
Efficacy of a short-term ribavirin plus interferon alpha combination therapy followed by interferon alpha alone in previously untreated patients withchronic hepatitis C: a randomized multicenter trial
Authors: Berg, T Hoffmann, RM Teuber, G Leifeld, L Lafrenz, M Baumgarten, R Spengler, U Zeuzem, S Pape, GR Hopf, U
Citation: T. Berg et al., Efficacy of a short-term ribavirin plus interferon alpha combination therapy followed by interferon alpha alone in previously untreated patients withchronic hepatitis C: a randomized multicenter trial, LIVER, 20(6), 2000, pp. 427-436
Semi-quantification of human C-C chemokine mRNAs with reverse transcription/real-time PCR using multi-specific standards
Authors: Dumoulin, FL Nischalke, HD Leifeld, L von dem Bussche, A Rockstroh, JK Sauerbruch, T Spengler, U
Citation: Fl. Dumoulin et al., Semi-quantification of human C-C chemokine mRNAs with reverse transcription/real-time PCR using multi-specific standards, J IMMUNOL M, 241(1-2), 2000, pp. 109-119
Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure
Authors: Streetz, K Leifeld, L Grundmann, D Ramakers, J Eckert, K Spengler, U Brenner, D Manns, M Trautwein, C
Citation: K. Streetz et al., Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure, GASTROENTY, 119(2), 2000, pp. 446-460
Retreatment with interferon-alpha and ribavirin in primary interferon-alpha non-responders with chronic hepatitis C
Authors: Teuber, G Berg, T Hoffmann, RM Leifeld, L Lafrenz, M Spengler, U Pape, GR Hopf, U Zeuzem, S
Citation: G. Teuber et al., Retreatment with interferon-alpha and ribavirin in primary interferon-alpha non-responders with chronic hepatitis C, DIGESTION, 61(2), 2000, pp. 90-97
Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis
Authors: Dumoulin, FL Leifeld, L Sauerbruch, T Spengler, U
Citation: Fl. Dumoulin et al., Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis, BIOMED PHAR, 53(5-6), 1999, pp. 242-254
Interferon-antibodies and the breakthrough phenomenon during ribavirin/interferon-alpha combination therapy and interferon-alpha monotherapy of patients with chronic hepatitis C
Authors: Hoffmann, RM Berg, T Teuber, G Prummer, O Leifeld, L Jung, MC Spengler, U Zeuzem, S Hopf, U Pape, GR
Citation: Rm. Hoffmann et al., Interferon-antibodies and the breakthrough phenomenon during ribavirin/interferon-alpha combination therapy and interferon-alpha monotherapy of patients with chronic hepatitis C, Z GASTROENT, 37(8), 1999, pp. 715-723
Intrahepatic expression of interleukin-1 beta and tumor necrosis factor-alpha in chronic hepatitis C
Authors: Dumoulin, FL Leifeld, L Honecker, U Sauerbruch, T Spengler, U
Citation: Fl. Dumoulin et al., Intrahepatic expression of interleukin-1 beta and tumor necrosis factor-alpha in chronic hepatitis C, J INFEC DIS, 180(5), 1999, pp. 1704-1708
Semiquantitation of human chemokine mRNA levels with a newly constructed multispecific competitor fragment
Authors: Dumoulin, FL Altfeld, M Rockstroh, JK Leifeld, L Sauerbruch, T Spengler, U
Citation: Fl. Dumoulin et al., Semiquantitation of human chemokine mRNA levels with a newly constructed multispecific competitor fragment, J IMMUNOL M, 224(1-2), 1999, pp. 61-67
Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure
Authors: Leifeld, L Trautwein, C Dumoulin, FL Manns, MP Sauerbruch, T Spengler, U
Citation: L. Leifeld et al., Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure, AM J PATH, 154(6), 1999, pp. 1711-1720
Risultati: 1-13 |